GHK-Cu, short for Glycyl-L-Histidyl-L-Lysine-Copper, is a naturally occurring copper-binding tripeptide that the body produces on its own, just in gradually smaller amounts as the years go by. That natural decline is part of why interest in GHK-Cu therapy has grown, but a declining peptide level alone doesn't automatically make someone a candidate. Good candidacy is really about matching a specific concern, skin quality, wound healing, or hair thinning, to a compound whose biological activity plausibly addresses it, and then confirming with a provider that there's nothing in a person's health history that would make it inappropriate.
Why GHK-Cu Levels Matter With Age
GHK-Cu occurs naturally in human plasma, and its levels follow a clear age-related pattern. Circulating levels peak in early adulthood, around 200 nanograms per milliliter in the early twenties, and decline substantially from there, dropping to roughly 80 nanograms per milliliter by age 60. That decline tracks closely with the visible and functional signs many people associate with aging skin and slower tissue repair, which is the rationale behind using supplemental GHK-Cu to support processes the body produced more of at a younger age. This makes adults in midlife and beyond, who are noticing these age-related changes rather than dealing with an unrelated acute issue, one of the more natural candidate groups for the therapy.
The Main Candidate Profiles
Skin quality and visible aging. This is the most established use case. GHK-Cu's copper component is a required cofactor for the enzymes that cross-link and stabilize newly made collagen, and the peptide also stimulates fibroblast activity, boosting production of collagen types I and III, elastin, and other structural proteins that keep skin firm and elastic. Adults noticing fine lines, mottled pigmentation, loss of elasticity, or generally poor skin texture are typically the clearest candidates for topical GHK-Cu formulations.
Wound healing and tissue repair. GHK-Cu accelerates several distinct phases of wound healing at once, including modulating the inflammatory phase, stimulating the proliferative phase, and supporting collagen remodeling as a wound closes. Research has documented healing-time reductions in the range of 30 to 50 percent for various wound types when GHK-Cu is used. This makes people recovering from surgery, traumatic injury, or slow-healing wounds, including chronic wounds like diabetic ulcers, a group where the therapy's biological rationale is strongest.
Hair thinning and follicle support. GHK-Cu has been studied for its effects on hair follicles, and clinical interest in this application has grown alongside interest in its skin effects. The most favorable candidates for hair-related use tend to be those with diffuse thinning, early-stage androgenetic alopecia where follicles haven't yet become permanently miniaturized, or inflammatory scalp conditions contributing to shedding, since GHK-Cu works by supporting follicle signaling rather than reversing follicles that have already been lost.
Matching the Form to the Goal
Candidacy also depends on which form of GHK-Cu actually fits the goal, since the peptide is used differently depending on what's being targeted. Topical formulations, serums and creams, are generally best suited to localized skin concerns like fine lines, pigmentation, and scalp or hair health, and represent the lowest-barrier entry point for someone primarily interested in cosmetic skin support. Subcutaneous injection is more often considered for broader systemic goals, such as more general tissue repair, hair regrowth, or recovery from a more significant injury, and requires medical supervision. Intravenous administration offers the highest bioavailability and is typically reserved for systemic recovery or more involved regenerative goals, again under a provider's direct oversight. Someone whose only concern is fine lines around the eyes is a very different candidate, in terms of appropriate form, than someone recovering from a surgical wound.
Who Should Be Cautious or Avoid GHK-Cu
Because GHK-Cu is fundamentally a copper-delivery molecule, certain conditions change the risk-benefit picture. Known copper sensitivity or a condition like Wilson's disease, which impairs the body's ability to regulate copper, is a clear reason for caution or avoidance, since supplemental copper could compound an existing regulatory problem. Active malignancy is another commonly cited contraindication, since a peptide that promotes angiogenesis and cell proliferation is generally considered inappropriate to introduce alongside active cancer without a specialist's direct involvement. Pregnancy is also typically listed as a reason to avoid GHK-Cu therapy, given the lack of safety data in that population. None of these are conditions a person can reliably rule out on their own, which is exactly why a physician evaluation, not just personal interest in the benefits, is the deciding factor in candidacy.
Setting Realistic Expectations
Even among good candidates, it's worth being clear-eyed about the evidence base. GHK-Cu's skin and topical wound-healing effects rest on a substantial body of laboratory and clinical research, but the evidence for systemic, injectable use, particularly for broader anti-aging claims, is thinner and still considered experimental, without large-scale human trials to confirm effect sizes. A good candidate is someone who understands that visible changes, when they occur, tend to build gradually over weeks to months, and who views GHK-Cu as one component of a broader plan rather than a standalone solution to skin aging, hair loss, or tissue repair.
The Bottom Line
The strongest candidates for GHK-Cu therapy are generally healthy adults dealing with age-related skin changes, slow-healing wounds or post-surgical recovery, or early-stage hair thinning, who have been evaluated by a provider and cleared of contraindications like copper sensitivity, active malignancy, or pregnancy. Because the right form, topical, injectable, or IV, depends heavily on the specific goal, and because the evidence base is stronger for some applications than others, an individualized medical evaluation is the only reliable way to determine whether GHK-Cu is the right fit for a given person's situation.